Suppression of inflammation by tumor-derived exosomes: A kind of natural liposome packaged with multifunctional proteins

Journal of Liposome Research

Volumn 22, Issue 4, 2012, Pages 346-352

  Teng, Hong ^a   Hu, Min ^b   Yuan, Li Xing ^b   Liu, Yuejian ^a   Guo, Xia ^b   Zhang, Wen Jing ^b   Jia, Rui Zhen ^b  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Anti immunity; Anti inflammation; Mutual complementarities; Tumor derived exosomes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIPOSOME;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CACHEXIA; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXICITY; DIARRHEA; DNA FRAGMENTATION; EXOSOME; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MEMBRANE VESICLE; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REFLEX; TISSUE SECTION; URINALYSIS;

ANIMALS; EXOSOMES; FEMALE; INFLAMMATION; LIPOSOMES; MICE; MICE, INBRED BALB C; NEOPLASMS;

EID: 84870261424     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.710911     Document Type: Article

References (29)

1. Abrahams, V. M., Straszewski, S. L., Kamsteeg, M., Hanczaruk, B., Schwartz, P. E., Rutherford, T. J., et al. (2003). Epithelial ovarian cancer cells secret functional Fas ligand. Can Res, 63:5573-5581. (Pubitemid 37139880)
2. Abusamra, A. J., Zhong, Z., Zheng, X., Li, M., Ichim, T. E., Chin, J. L., et al. (2005). Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cell Mol Dis 35:169-173. (Pubitemid 41267045)
3. Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., et al. (2002). Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195:1303-1316. (Pubitemid 34564332)
4. Bianco, N. R., Kim, S. H., Rufner, M. A., Robbins, P. D. (2009). Terapeutic efect of exosomes from indoleamine 2, 3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. Arth Rheum 60:380-389.
5. Cho, J. A., Yeo, D. J., Son, H. Y., Kim, H. W., Jung, D. S., Ko, J. K., et al. (2004). Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Inter J Can 114:613-622.
6. Frängsmyr, L., Baranov, V., Nagaeva, O., Stendahl, U., Kjellberg, L., Mincheva-Nilsson, L. (2005). Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 11:35-41. (Pubitemid 40331001)
7. Gong, J. P., Traganos, F., Darzynkiewicz, Z. (1994). A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and fow cytometry. Anal Biochem 218:314-319. (Pubitemid 24141629)
8. Gutwein, P., Mechtersheimer, S., Riedle, S., Stoeck, A., Gast, D., Joumaa, S., et al. (2003). ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17:292-294.
9. Hand, C. M., Vender, J. R., Black, P. (1988). Chemotherapy in experimental brain tumor, part 1: in vitro colorimetric MTT assay. J Neurooncol 36:1-6.
10. Hegmans J. P., Bard M. P., Hemmes, A., Luider, T. M., Kleijmeer M. J., Prins, J. B., et al. (2004). Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 164:1807-1815. (Pubitemid 38529783)
11. Jiang, P. D., Zhao, Y. L., Shi, W., Deng, X. Q., Xie, G., Mao, Y. Q., et al. (2008). Cell growth inhibition, G2/M cell cycle arrest, and apoptosis induced by chloroquine in human breast cancer cell line Bcap-37. Cell Physiol Biochem 22:431-440.
12. Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., Turbide, C. (1987). Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262:9412-9420.
13. Kim, C. W., Lee, H. M., Lee, T. H., Kang, C., Kleinman, H. K., Gho, Y. S. (2002). Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 62:6312-6317. (Pubitemid 35244486)
14. Liu, J. Y., Wei, Y. Q., Yang, L., Zhao, X., Tian, L., Hou, J. M., et al. (2003). Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 102:1815-1823. (Pubitemid 37022578)
15. MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., Surprenant, A. (2001). Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15:825-835. (Pubitemid 34008509)
16. Monleón, I., Martínez-Lorenzo, M. J., Monteagudo, L., Lasierra, P., Taulés, M., Iturralde, M., et al. (2001). Diferential secretion of Fas ligand or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesiclesduring activation-induced death of human T cells. J Immunol 167:6736-6744. (Pubitemid 33144163)
17. Morelli, A. E., Larregina, A. T., Shufesky, W. J., Sullivan, M. L. G., Stolz, D. B., et al. (2004). Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104:3257-3266. (Pubitemid 39507144)
18. Redman, C. W. G., Sargent, I. L. (2007). Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol 76:61-67. (Pubitemid 350100875)
19. Staubach, S., Razawi, H., Hanisch, F. G. (2009). Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 9:2820-2835.
20. Su, J. M., Wei, Y. Q., Tian, L., Zhao, X., Yang, L., He, Q. M., et al. (2003). Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res 63:600-607. (Pubitemid 36158137)
21. Taylor, D. D., Akyol, S., Gercel-Taylor, C. (2006). Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 176:1534-1542. (Pubitemid 43134297)
22. Taylor, D. D., Gercel-Taylor, C. (2005). Tumor-derived exosomes and their role in cancer-associated T-cell signaling defects. Br J Cancer 92:305-311. (Pubitemid 40343146)
23. Taylor, D. D., Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110:13-21. (Pubitemid 351853251)
24. Taylor, D. D., Homesley, H. D., Doellgast, G. J. (1983). Membrane-associated immunoglobulins in cytst and ascites fuids of ovarian cancer patients. Am J Reprod Immunol 3:7-11. (Pubitemid 13056133)
25. Téry, C., Zitvogel, L., Amigorena, S. (2002). Exosomes: composition, biogenesis, and function. Nat Rev Immunol 2:569-579.
26. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. L., Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659. (Pubitemid 47214727)
27. Wei, Y. Q., Wang, Q. R., Zhao, X., Yang, L., Tian, L., Lu, Y., et al. (2000). Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 6:1160-1166.
28. Whiteside, T. L. (2005). Tumor-derived exosomes or microvesicles: another mechanism of tumor escape from the host immune system. Br J Cancer 92:209-211. (Pubitemid 40343129)
29. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Téry, C., Masurier, C., et al. (2001). Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297-303. (Pubitemid 32224344)